Seshu Tyagarajan - Net Worth and Insider Trading
Seshu Tyagarajan Net Worth
The estimated net worth of Seshu Tyagarajan is at least $667,444 dollars as of 2024-12-03. Seshu Tyagarajan is the Chief Technology Officer of Candel Therapeutics Inc and owns about 146,049 shares of Candel Therapeutics Inc (CADL) stock worth over $667,444. Details can be seen in Seshu Tyagarajan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Seshu Tyagarajan has not made any transactions after 2024-07-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Seshu Tyagarajan
Seshu Tyagarajan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Seshu Tyagarajan owns 1 companies in total, including Candel Therapeutics Inc (CADL) .
Click here to see the complete history of Seshu Tyagarajan’s form 4 insider trades.
Insider Ownership Summary of Seshu Tyagarajan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CADL | Candel Therapeutics Inc | 2024-07-17 | See Remarks |
Seshu Tyagarajan Latest Holdings Summary
Seshu Tyagarajan currently owns a total of 1 stock. Seshu Tyagarajan owns 146,049 shares of Candel Therapeutics Inc (CADL) as of July 17, 2024, with a value of $667,444.
Latest Holdings of Seshu Tyagarajan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CADL | Candel Therapeutics Inc | 2024-07-17 | 146,049 | 4.57 | 667,444 |
Holding Weightings of Seshu Tyagarajan
Seshu Tyagarajan Form 4 Trading Tracker
According to the SEC Form 4 filings, Seshu Tyagarajan has made a total of 3 transactions in Candel Therapeutics Inc (CADL) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in Candel Therapeutics Inc is the sale of 14,851 shares on July 17, 2024, which brought Seshu Tyagarajan around $96,086.
Insider Trading History of Seshu Tyagarajan
- 1
Seshu Tyagarajan Trading Performance
GuruFocus tracks the stock performance after each of Seshu Tyagarajan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Seshu Tyagarajan is -16.27%. GuruFocus also compares Seshu Tyagarajan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Seshu Tyagarajan within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Seshu Tyagarajan's insider trading performs compared to the benchmark.
Performance of Seshu Tyagarajan
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -5.26 | | | | | |
| Relative Return to S&P 500(%) | -4.19 | | | | | |
Seshu Tyagarajan Ownership Network
Seshu Tyagarajan Owned Company Details
What does Candel Therapeutics Inc do?
Who are the key executives at Candel Therapeutics Inc?
Seshu Tyagarajan is the See Remarks of Candel Therapeutics Inc. Other key executives at Candel Therapeutics Inc include director & Chief Scientific Officer Estuardo Aguilar-cordova , Chief Medical Officer William Garrett Nichols , and Chief Scientific Officer Francesca Barone .
Candel Therapeutics Inc (CADL) Insider Trades Summary
Over the past 18 months, Seshu Tyagarajan made 2 insider transaction in Candel Therapeutics Inc (CADL) with a net sale of 28,181. Other recent insider transactions involving Candel Therapeutics Inc (CADL) include a net sale of 75,414 shares made by Estuardo Aguilar-cordova , a net sale of 42,821 shares made by Paul Peter Tak , and a net sale of 26,696 shares made by Francesca Barone .
In summary, during the past 3 months, insiders sold 75,414 shares of Candel Therapeutics Inc (CADL) in total and bought 0 shares, with a net sale of 75,414 shares. During the past 18 months, 212,537 shares of Candel Therapeutics Inc (CADL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 212,537 shares.
Candel Therapeutics Inc (CADL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Candel Therapeutics Inc Insider Transactions
Seshu Tyagarajan Mailing Address
Above is the net worth, insider trading, and ownership report for Seshu Tyagarajan. You might contact Seshu Tyagarajan via mailing address: Candel Therapeutics, Inc., 117 Kendrick St Suite 450, Needham Ma 02494.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
